Drugs / BAY1193397
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03128320 | May 2017 → Sep 2019 | — | Bayer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BAY1193397 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03128320 ↗ |
| Route | Oral | “Single oral dose of 1 mg BAY1193397” NCT03128320 ↗ |